Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Century Therapeutics (IPSC) Tax Provisions (2022 - 2024)

Historic Tax Provisions for Century Therapeutics (IPSC) over the last 3 years, with Q4 2024 value amounting to $1.8 million.

  • Century Therapeutics' Tax Provisions rose 30508.08% to $1.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.8 million, marking a year-over-year decrease of 493.63%. This contributed to the annual value of $1.8 million for FY2024, which is 498.94% down from last year.
  • According to the latest figures from Q4 2024, Century Therapeutics' Tax Provisions is $1.8 million, which was up 30508.08% from -$8000.0 recorded in Q3 2024.
  • In the past 5 years, Century Therapeutics' Tax Provisions registered a high of $1.8 million during Q4 2024, and its lowest value of -$866000.0 during Q4 2023.
  • Its 3-year average for Tax Provisions is $313833.3, with a median of $23500.0 in 2022.
  • Within the past 5 years, the most significant YoY rise in Century Therapeutics' Tax Provisions was 745000.0% (2023), while the steepest drop was 280625.0% (2023).
  • Century Therapeutics' Tax Provisions (Quarter) stood at $32000.0 in 2022, then plummeted by 2806.25% to -$866000.0 in 2023, then soared by 305.08% to $1.8 million in 2024.
  • Its Tax Provisions was $1.8 million in Q4 2024, compared to -$8000.0 in Q3 2024 and $22000.0 in Q2 2024.